↓ Skip to main content

Genome-wide screening identifies new genes required for stress-induced phase 2 detoxification gene expression in animals

Overview of attention for article published in BMC Biology, August 2014
Altmetric Badge

Mentioned by

twitter
4 X users
patent
1 patent

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Genome-wide screening identifies new genes required for stress-induced phase 2 detoxification gene expression in animals
Published in
BMC Biology, August 2014
DOI 10.1186/s12915-014-0064-6
Pubmed ID
Authors

Helen M Crook-McMahon, Monika Oláhová, Emma L Button, Johnathan J Winter, Elizabeth A Veal

Abstract

BackgroundPhase 2 detoxification enzymes provide a vital defense against reactive oxygen species, including xenobiotic metabolites, that cause oxidative damage involved in drug toxicity and many diseases. Hence, there is great interest in understanding how levels of these enzymes are regulated. CnC transcription factors, such as mammalian Nrf2, drive the expression of phase 2 enzymes and are activated as an important conserved response to oxidative stress and xenobiotics. For instance, the Caenorhabditis elegans Nrf2 ortholog, SKN-1, is activated in response to arsenite by the stress-activated p38-related kinase, PMK-1, leading to increased expression of phase 2 enzymes. Here we have used a genome-wide screening approach to identify other C. elegans genes that are required for stress-induced increases in phase 2 detoxification gene expression.ResultsTaking advantage of the elevated phase 2 gene expression in a mutant lacking the peroxidase PRDX-2, we have identified many new genes that are required for stress-induced expression of gcs-1, a phase 2 enzyme critically required for glutathione synthesis. Significantly, these include genes previously implicated in resistance to ionizing radiation, longevity, and responses to pathogenic infection. Many of these new candidate activators of gcs-1 are also required for the stress-induced intestinal expression of other phase 2 genes. However, intriguingly, our data suggest other factors may be specifically required for the stress-induced expression of gcs-1. Notably, we demonstrate that the candidate activator TIR-1(SARM1) and the MAPKKK NSY-1(Ask1) are required for the arsenite-induced activation of PMK-1. However, our data suggest that the majority of candidates participate in novel mechanisms to promote gcs-1 expression. For example, the E4 ubiquitin ligase UFD-2(UBE4B) is dispensable for PMK-1 activation but important for maintaining nuclear levels of SKN-1, the stress-induced expression of multiple SKN-1-target genes and oxidative stress resistance.ConclusionsHere we present the first functional, genome-wide analysis identifying genes that are required for activation of phase 2 detoxification genes in an animal. Our study identifies potential new regulators of Nrf2; reveals that additional mechanisms promote the stress-induced expression of specific phase 2 detoxification genes; and provides new insight into the relationships between these universally important stress defenses, oxidative stress resistance and aging.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Germany 1 2%
Unknown 52 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 33%
Researcher 9 16%
Student > Doctoral Student 5 9%
Other 3 5%
Professor > Associate Professor 3 5%
Other 11 20%
Unknown 6 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 40%
Biochemistry, Genetics and Molecular Biology 14 25%
Neuroscience 2 4%
Immunology and Microbiology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 3 5%
Unknown 11 20%